302 related articles for article (PubMed ID: 3141780)
21. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
Leonard JE; Wang QC; Kaplan NO; Royston I
Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
[TBL] [Abstract][Full Text] [Related]
22. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht LD; Griffin TW; Raso V; Salimi AR
Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
[TBL] [Abstract][Full Text] [Related]
23. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.
Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA
J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676
[TBL] [Abstract][Full Text] [Related]
24. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
Griffin TW; Childs LR; FitzGerald DJ; Levin LV
J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
[TBL] [Abstract][Full Text] [Related]
27. Streptavidin-biotin immunotoxins: a new approach to purging bone marrow.
Meyer BF; Stoner ML; Raphael CL; Davis RE; Herrmann RP
Exp Hematol; 1991 Aug; 19(7):710-3. PubMed ID: 1893957
[TBL] [Abstract][Full Text] [Related]
28. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
Lambert JM; Goldmacher VS; Collinson AR; Nadler LM; Blättler WA
Cancer Res; 1991 Dec; 51(23 Pt 1):6236-42. PubMed ID: 1718599
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens.
Colombatti M; Bron C
Immunology; 1985 Jun; 55(2):331-8. PubMed ID: 2861156
[TBL] [Abstract][Full Text] [Related]
30. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin.
DeShambo RM; Krolick KA
J Immunol; 1986 Nov; 137(10):3135-9. PubMed ID: 3490511
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
[TBL] [Abstract][Full Text] [Related]
32. Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.
Gregg EO; Bridges SH; Youle RJ; Longo DL; Houston LL; Glennie MJ; Stevenson FK; Green I
J Immunol; 1987 Jun; 138(12):4502-8. PubMed ID: 3495593
[TBL] [Abstract][Full Text] [Related]
33. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.
Pincus SH; Wehrly K; Chesebro B
J Immunol; 1989 May; 142(9):3070-5. PubMed ID: 2540236
[TBL] [Abstract][Full Text] [Related]
34. [Selective cytotoxic effect of an immunotoxin on human erythroid tumor cells].
Tonevitskiĭ AG; Agapov II; Mechetner EB
Mol Biol (Mosk); 1991; 25(5):1181-7. PubMed ID: 1753950
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
Lopes de Menezes DE; Pilarski LM; Allen TM
Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
[TBL] [Abstract][Full Text] [Related]
36. Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.
Godal A; Fodstad O; Morgan AC; Pihl A
J Natl Cancer Inst; 1986 Dec; 77(6):1247-53. PubMed ID: 3491924
[TBL] [Abstract][Full Text] [Related]
37. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
Raso V; Griffin T
J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
[TBL] [Abstract][Full Text] [Related]
38. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.
Sivam G; Pearson JW; Bohn W; Oldham RK; Sadoff JC; Morgan AC
Cancer Res; 1987 Jun; 47(12):3169-73. PubMed ID: 3495329
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
[TBL] [Abstract][Full Text] [Related]
40. Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.
Cogliati T; Brusa P; Canevari S; Caldera M; Mezzanzanica D; Dosio F; Cattel L; Colnaghi MI
Anticancer Res; 1991; 11(1):417-21. PubMed ID: 2018380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]